Clarus IV-A, L.P. 4

Accession 0000899243-19-027290

CIK 0001563577other

View on SEC.gov Company Profile

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 5:00 PM ET

Size

38.5 KB

Accession

0000899243-19-027290

Insider Transaction Report

Form 4

Period: 2019-11-12

Galera Therapeutics, Inc.GRTX

Clarus IV-B, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-11-12+301,001→ 301,001 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+111,021→ 111,021 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+80,786$969,432→ 542,555 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+97,131$1,165,572→ 652,324 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+19,423$233,076→ 130,444 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,334,966→ 0 total(indirect: See Footnotes)
→ Common Stock (461,769 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−1,552,035→ 0 total(indirect: See Footnotes)
→ Common Stock (301,001 underlying)
Conversion
Common Stock
2019-11-12+461,769→ 461,769 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,807,372→ 0 total(indirect: See Footnotes)
→ Common Stock (555,193 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−561,385→ 0 total(indirect: See Footnotes)
→ Common Stock (111,021 underlying)
Conversion
Common Stock
2019-11-12+555,193→ 555,193 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+52,660$631,920→ 353,661 total(indirect: See Footnotes)

Clarus IV-C, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-11-12+461,769→ 461,769 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+555,193→ 555,193 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+80,786$969,432→ 542,555 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+97,131$1,165,572→ 652,324 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−1,552,035→ 0 total(indirect: See Footnotes)
→ Common Stock (301,001 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,807,372→ 0 total(indirect: See Footnotes)
→ Common Stock (555,193 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,334,966→ 0 total(indirect: See Footnotes)
→ Common Stock (461,769 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−561,385→ 0 total(indirect: See Footnotes)
→ Common Stock (111,021 underlying)
Conversion
Common Stock
2019-11-12+301,001→ 301,001 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+111,021→ 111,021 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+52,660$631,920→ 353,661 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+19,423$233,076→ 130,444 total(indirect: See Footnotes)

Clarus IV-D, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-11-12+461,769→ 461,769 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+555,193→ 555,193 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+111,021→ 111,021 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+80,786$969,432→ 542,555 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+52,660$631,920→ 353,661 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−561,385→ 0 total(indirect: See Footnotes)
→ Common Stock (111,021 underlying)
Conversion
Common Stock
2019-11-12+301,001→ 301,001 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,334,966→ 0 total(indirect: See Footnotes)
→ Common Stock (461,769 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,807,372→ 0 total(indirect: See Footnotes)
→ Common Stock (555,193 underlying)
Purchase
Common Stock
2019-11-12$12.00/sh+97,131$1,165,572→ 652,324 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+19,423$233,076→ 130,444 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−1,552,035→ 0 total(indirect: See Footnotes)
→ Common Stock (301,001 underlying)

Clarus IV-A, L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-11-12+301,001→ 301,001 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−561,385→ 0 total(indirect: See Footnotes)
→ Common Stock (111,021 underlying)
Conversion
Common Stock
2019-11-12+461,769→ 461,769 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+555,193→ 555,193 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+111,021→ 111,021 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+80,786$969,432→ 542,555 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+52,660$631,920→ 353,661 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+97,131$1,165,572→ 652,324 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+19,423$233,076→ 130,444 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,334,966→ 0 total(indirect: See Footnotes)
→ Common Stock (461,769 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−1,552,035→ 0 total(indirect: See Footnotes)
→ Common Stock (301,001 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,807,372→ 0 total(indirect: See Footnotes)
→ Common Stock (555,193 underlying)

Clarus IV GP L.P.

10% Owner

Transactions

Conversion
Common Stock
2019-11-12+461,769→ 461,769 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+111,021→ 111,021 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+80,786$969,432→ 542,555 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+19,423$233,076→ 130,444 total(indirect: See Footnotes)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,334,966→ 0 total(indirect: See Footnotes)
→ Common Stock (461,769 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−1,552,035→ 0 total(indirect: See Footnotes)
→ Common Stock (301,001 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−2,807,372→ 0 total(indirect: See Footnotes)
→ Common Stock (555,193 underlying)
Conversion
Series C Redeemable Convertible Preferred Stock
2019-11-12−561,385→ 0 total(indirect: See Footnotes)
→ Common Stock (111,021 underlying)
Conversion
Common Stock
2019-11-12+301,001→ 301,001 total(indirect: See Footnotes)
Conversion
Common Stock
2019-11-12+555,193→ 555,193 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+52,660$631,920→ 353,661 total(indirect: See Footnotes)
Purchase
Common Stock
2019-11-12$12.00/sh+97,131$1,165,572→ 652,324 total(indirect: See Footnotes)

Footnotes (9)

[F1]These shares of the Issuer's Series C redeemable convertible preferred stock ("Redeemable Convertible Preferred Stock") are convertible into shares of the Issuer's common stock ("Common Stock") on a 0.197763-for-one basis at the holder's election and have no expiration date. The Redeemable Convertible Preferred Stock will automatically convert into Common Stock upon the closing of the Issuer's initial public offering.
[F2]These securities are held directly by Clarus IV-A, L.P.
[F3]These securities are held directly by Clarus IV-B, L.P.
[F4]These securities are held directly by Clarus IV-C, L.P.
[F5]These securities are held directly by Clarus IV-D, L.P. (collectively, with Clarus IV-A, L.P., Clarus IV-B, L.P. and Clarus IV-C, L.P., the "Clarus Funds").
[F6]The general partner of each of the Clarus Funds is Clarus IV GP, L.P. The general partner of Clarus IV GP, L.P. is Blackstone Clarus GP L.P. The general partner of Blackstone Clarus GP L.P. is Blackstone Clarus GP L.L.C. The sole member of Blackstone Clarus GP L.L.C. is Blackstone Holdings II L.P. The general partner of Blackstone Holdings II L.P. is Blackstone Holdings I/II GP L.L.C. The sole member of Blackstone Holdings I/II GP L.L.C. is The Blackstone Group Inc. The sole holder of the Class C common stock of The Blackstone Group Inc. is Blackstone Group Management L.L.C. Blackstone Group Management L.L.C. is wholly-owned by Blackstone's senior managing directors and controlled by its founder, Stephen A. Schwarzman.
[F7]Due to the limitations of the electronic filing system certain Reporting Persons are filing a separate Form 4.
[F8]Information with respect to each of the Reporting Persons is given solely by such Reporting Person, and no Reporting Person has responsibility for the accuracy or completeness of information supplied by another Reporting Person.
[F9]Each of such Reporting Persons may be deemed to beneficially own the securities reported herein directly or indirectly controlled by it or him, but each (other than the Clarus Funds to the extent of their direct holdings) disclaims beneficial ownership of such securities, except to the extent of such Reporting Person's pecuniary interest therein. The filing of this statement shall not be deemed to be an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934 or otherwise, the Reporting Persons are the beneficial owners of any securities reported herein.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Galera Therapeutics, Inc.

CIK 0001563577

→

Entity typeother

IncorporatedDE

Related Parties

filerCIK 0001700720

Filing Metadata

Form type: 4
Filed: Nov 13, 7:00 PM ET
Accepted: Nov 14, 5:00 PM ET
Size: 38.5 KB

View on SEC.gov